Advertisement

Neurotransmitter Systems in the Central Nervous System

  • Norman Weiner
Part of the Advances in Behavioral Biology book series (ABBI, volume 8)

Abstract

In a simplistic fashion, one might surmise that the entire purpose of neuronal development is to construct the mechanisms for interneuronal communication. Since interneuronal communication in mammalian systems involves chemical transmission, one might reason further that the ultimate purpose of central nervous system development is to develop mechanisms for the synthesis, storage and release of the substances which effect this interneuronal communication, the transmitters. The dynamics of neurotransmitter metabolism in the adult peripheral nervous system is quite well understood. At least in some systems we are beginning to develop very considerable knowledge of neurotransmitter mechanisms in the adult central nervous system. In this introduction to our session on development of neurotransmission, I shall briefly review the dynamics of neurotransmitter metabolism in, and the neuropharmacology of, a few of these systems. The development of these systems will be discussed in more detail by the principal speakers of this session.

Keywords

Tyrosine Hydroxylase Postsynaptic Receptor Developmental Aspect Lysergic Acid Diethylamide Neurotransmitter Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aghajanian, G.K., Foote, W.E. and Sheard, M.H., 1970, Action of psychotogenic drugs on single midbrain raphe neurons. J. Pharmacol. Exp. Ther. 171: 178–187.Google Scholar
  2. Aprison, M.H., Hariya, T., Hingtgen, J.N. and Toru, M., 1968, Neuro-Google Scholar
  3. Axelrod, J., 1959, Metabolism of epinephrine and other sympathomimetic amines. Physiol. Rev. 39: 751–776.Google Scholar
  4. Bender, D.A. and Coulson, W.F., 1972, Variations in aromatic amino acid decarboxylase activity towards dopa and 5-hydroxytryptophan caused by pH changes and denaturation. J. Neurochem. 19: 2801–2810.PubMedCrossRefGoogle Scholar
  5. Bjärklund, A., Ehinger, B. and Falck, B., 1968, A method for differentiating dopamine from noradrenaline in tissue sections by microspectrofluorometry. J. Histochem. Cvtochem. 16: 263–270.Google Scholar
  6. Brimijoin, S. and Molinoff, P.B., 1971, Effects of 6-hydroxydopamine on the activity of tyrosine hydroxylase and dopamine-13-hydroxylase in sympathetic ganglia of the rat. J. Pharmacol. Exp. Ther. 178: 417–424.Google Scholar
  7. Campbell, L.B. and Jenden, D.J., 1970, Gas chromatographic evalulation of the influence of oxotremorine upon the regional distribution of acetylcholine in rat brain. J. Neurochem. 17: 1697–1699.PubMedCrossRefGoogle Scholar
  8. Christenson, J.C., Dairman, W. and Udenfriend, S., 1972, On the identity of DOPA decarboxylase and 5-hydroxytryptophan de-carboxylase. Proc. Natn. Acad. Sci., U.S.A. 69: 343–347.Google Scholar
  9. Coyle, J.T. and Axelrod, J., 1972a, Dopamine-ß-hydroxylase in rat brain: Developmental characteristics. J. Neurochem. 19: 449–459.Google Scholar
  10. Coyle, J.T. and Axelrod, J., 1972b, Tyrosine hydroxylase in rat brain: Developmental characteristics. J. Neurochem. 19: 1117–1123.Google Scholar
  11. Dahlström, A., 1970, The effects of drugs on axonal transport of amine storage granules. In: New Aspects of Storage and Release Mechanisms of Catecholamines. Bayer Symposium II ( H.J. Schumann and G. Kroneberg, Eds.) Springer-Verlag, Berlin, pp. 20–36.CrossRefGoogle Scholar
  12. Dairman, W., Gordon, R., Spector, S., Sjoerdsma, A. and Udenfriend, S., 1968, Increased synthesis of catecholamines in the intact rat following administration of U-adrenergic blocking agents. Molec. Pharmacol. 457–464.Google Scholar
  13. Deguchi, T. and Barchas, J., 1972, Regional distribution and developmental change of tryptophan hydroxylase in rat brain. J. Neurochem. 19: 927–929.PubMedCrossRefGoogle Scholar
  14. Falck, B., Hillarp, N.-K., Thieme, G. and Torp, A., 1962, Fluorescence of catecholamines and related compounds condensed with formaldehyde. J. Histochem. Cytochem. 10: 348–354.Google Scholar
  15. Falck, B. and Owman, Ch., 1965, A detailed methodological des- scription of biogenic monoamines. Acta Univ. Lund II 7: 1–23.Google Scholar
  16. Freedman, D.X., Gottlieb, R. and Lovell, R.A., 1970, Psychotomimetic drugs and brain 5-hydroxytryptamine metabolism. Biochem. Pharmacol. 19: 1181–1188.Google Scholar
  17. Hebb, C.O. and Krnjevic, K., 1962, The physiological significance of acetylcholine. In: Neurochemistry ( K.A.C. Elliott, I.H. Page and J.H. Quastel, Eds.) Charles C Thomas, Springfield pp. 452–521.Google Scholar
  18. Hillarp, N.-A., Fuxe, K. and Dahlstrom, A., 1966, Demonstration and mapping of central neurons containing dopamine, noradrenaline and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol. Rev. 18: 727–741.Google Scholar
  19. Holmstedt, B. and Lundgren, G., 1966, Tremorigenic agents and brain acetylcholine. In: Mechanisms of Release of Biogenic Amines. ( Euler, U.S. v., Rosell, S. and Uvnas, B., Eds.) Pergamon Press, Oxford, pp. 439–468.Google Scholar
  20. Holzbauer, M. and Sharman, D.F., 1972, The distribution of catecholamines in vertebrates. In: Catecholamines (H. Blaschko andGoogle Scholar
  21. E. Muscholl, Eds.) Springer-Verlag, Berlin, pp. 110–185.Google Scholar
  22. Ichiyama, A., Nakamura, S., Nishizuka, Y. and Hayaishi, O., 1970, Enzymic studies on the biosynthesis of serotonin in mammalian brain. J. Biol. Chem. 245: 1699–1709.Google Scholar
  23. Kamberi, I.A., Mical, R.S. and Porter, J.C., 1971, Hypophyseal portal vessel infusion: In vivo demonstration of LRF, FRF and PIF in pituitary stalk plasma. Endocrinology 89: 1042–1046.Google Scholar
  24. Kindwall, E.P. and Weiner, N., 1966, The distribution and rates of formation of catecholamines in several regions of bovine brain. J. Neurochem. 13: 1523–1531.PubMedCrossRefGoogle Scholar
  25. Koe, B.K. and Weissman, A., 1966, p-Chlorophenylalanine. A specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 154: 499–516.Google Scholar
  26. Livett, B.G., 1973, Histochemical visualization of adrenergic neurones. Brit. Med. Bull. 29: 93–99.Google Scholar
  27. Marchisio, P.C., 1969, Choline acetyltransferase (ChAc) activity in developing chick optic centres and the effects of monolateral removal of retina at an early embryonic state and at hatching. J. Neurochem. 16: 665–671.Google Scholar
  28. Mueller, R.A., Thoenen, H. and Axelrod, J., 1969, Increase in tyrosine hydroxylase activity after reserpine administration. J. Pharmacol. Exp. Ther. 169: 74–79.Google Scholar
  29. O’Keeffe, R., Sharman, D.F. and Vogt, M., 1970, Effect of drugs used in psychoses on cerebral dopamine metabolism. Brit. J. Pharmacol. 38: 287–304.Google Scholar
  30. Quastel, J.H., 1962, Acetylcholine distribution and synthesis in the central nervous system. In: Neurochemistry ( K.A.C. Elliott, I.H. Page and J.H. Quastel, Eds.) Charles C Thomas, Springfield, pp. 431–451.Google Scholar
  31. Ritchie, J.M. and Greengard, P., 1966, On the mode of action of local anesthetics. Annu. Rev. Pharmacol. 6: 405–430.Google Scholar
  32. Robson, J.M. and Stacey, R.S., 1962, Recent Advances in Pharmacology, Third Ed., Little Brown & Co., Boston, pp. 1–41.Google Scholar
  33. Rutledge, C.O., Azzaro, A.J. and Ziance, R.J., 1972, The role of monoamine oxidase in determining the amount of monoamines released by drugs in the central nervous system. In: Monoamine Oxidases–New Vistas. ( E. Costa and M. Sandler, Eds.) Raven Press, New York, pp. 379–392.Google Scholar
  34. Rutledge, C.O. and Weiner, N., 1967, The effect of reserpine upon the synthesis of norepinephrine in the isolated rabbit heart. J. Pharmacol. Exp. Ther. 157: 290–302.Google Scholar
  35. Schneider, H.P.G. and McKann, S.M., 1969, Possible role of dopamine as transmitter to promote discharge of LH-releasing factor. Endocrinology, 85: 121–132.PubMedCrossRefGoogle Scholar
  36. Sims, K.L., Davis, G.A. and Bloom, F.E., 1973, Activities of 3,4-dihydroxy-L-phenylalanine and 5-hydroxy-L-tryptophan decarboxylases in rat brain: Assay characteristics and distribution. J. Neurochem. 20: 449–464.Google Scholar
  37. Tenen, S.S., 1967, The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance acquisition, pain sensitivity and related behavior in the rat. Psychopharmacologia 10: 204–219.PubMedCrossRefGoogle Scholar
  38. Weiner, N., 1960, Substrate specificity of brain amine oxidase of several mammals. Arch. Biochem. 91: 182–188.Google Scholar
  39. Weiner, N., 1970, Regulation of norepinephrine biosynthesis. Annu. Rev. Pharmacol. 10: 273–290.Google Scholar
  40. Weiner, N., 1972, Pharmacology of central nervous system stimulants, In: International Symposium on Drug Abuse, ed. by C.J.D. Zarafonetis, Lea and Febiger, Phila. pp. 243–251.Google Scholar
  41. Woodbury, D.M., 1969, Mechanisms of action of anticonvulsants. In: Basic Mechanisms of the Epilepsies. ( Jasper, H.H., Ward, A.A., Jr. and Pope, A., Eds.) Little, Brown and Company, Boston, pp. 647–681.Google Scholar

Copyright information

© Plenum Press, New York 1974

Authors and Affiliations

  • Norman Weiner
    • 1
  1. 1.Department of PharmacologyUniversity of Colorado School of MedicineDenverUSA

Personalised recommendations